These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22546334)

  • 1. Actigraphic study of tremor before and after treatment with zonisamide in patients with Parkinson's disease.
    Mochio S; Sengoku R; Kono Y; Morita M; Mitsumura H; Takagi S; Kamiyama T; Oka H
    Parkinsonism Relat Disord; 2012 Aug; 18(7):906-8. PubMed ID: 22546334
    [No Abstract]   [Full Text] [Related]  

  • 2. Zonisamide in patients with essential tremor and Parkinson's disease.
    Bermejo PE
    Mov Disord; 2007 Oct; 22(14):2137-8. PubMed ID: 17853481
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of zonisamide on resting tremor resistant to antiparkinsonian medication].
    Nakanishi I; Kohmoto J; Miwa H; Kondo T
    No To Shinkei; 2003 Aug; 55(8):685-9. PubMed ID: 13677302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicophysiological study of tremor in Parkinson's disease: quantitative tremor-based assessment of motor count using actigraphy].
    Mochio S; Oka H; Katayama K; Sato H
    Nihon Rinsho; 1997 Jan; 55(1):158-62. PubMed ID: 9014442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zonisamide on experimental tremors in rats.
    Miwa H; Hama K; Kajimoto Y; Kondo T
    Parkinsonism Relat Disord; 2008; 14(1):33-6. PubMed ID: 17587636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor.
    Iijima M; Osawa M; Kobayashi M; Uchiyama S
    Eur J Neurol; 2011 Apr; 18(4):e43-4. PubMed ID: 21159065
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical treatment of essential tremor and Parkinson's disease.
    Uitti RJ
    Geriatrics; 1998 May; 53(5):46-8, 53-7. PubMed ID: 9597979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
    Miwa H; Kubo T; Suzuki A; Kondo T
    Parkinsonism Relat Disord; 2009 Jan; 15(1):30-5. PubMed ID: 18693129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide for seizures in Parkinson's disease with dementia.
    Tombini M; Pellegrino G; Di Pino G; Assenza G
    Seizure; 2013 May; 22(4):324-5. PubMed ID: 23403093
    [No Abstract]   [Full Text] [Related]  

  • 10. Zonisamide for the treatment of Parkinson's disease.
    Miwa H
    Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic response to zonisamide of post-subarachnoid hemorrhage Holmes' tremor.
    Suda S; Yamazaki M; Katsura K; Fukuchi T; Kaneko N; Ueda M; Nagayama H; Katayama Y
    J Neurol; 2012 Jan; 259(1):185-7. PubMed ID: 21647726
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA; Sabach T; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):250-2. PubMed ID: 17967525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide: a new drug for Parkinson's disease.
    Murata M
    Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Objective measurement of motor activity in Parkinson's disease by actigraphy. Clinical assessment of akinesia].
    Fujikane M; Katayama S; Hirata K; Yokota N
    Nihon Rinsho; 1997 Jan; 55(1):153-7. PubMed ID: 9014441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in Parkinson's disease: profile report.
    Yang LP; Perry CM
    Drugs Aging; 2010 Jan; 27(1):73-5. PubMed ID: 20030434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
    Wolters A; Benecke R
    MMW Fortschr Med; 2007 May; 149 Suppl 2():94-6. PubMed ID: 17724978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zonisamide co-administration with levodopa on global gene expression in the striata of rats with Parkinson's disease.
    Ueda Y; Tokashiki S; Kanemaru A; Kojima T
    Biochem Biophys Res Commun; 2012 Nov; 428(3):401-4. PubMed ID: 23103374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
    Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
    Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A; Martin FC; Kang GA; Vanek Z
    Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.